Upgrade to SI Premium - Free Trial

Guggenheim Remains Positive on Phibro Animal Health (PAHC), Raises Price Target to $40

May 12, 2015 11:34 AM
Guggenheim maintains a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and raised the price target to $40.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change Guidance

Next Articles